ABSTRACT
Exenteration has been used for six decades to treat selected mostly irradiated patients with locally advanced and recurrent cancer of the lower and middle female genital tract. The mainstay for treatment success in terms of locoregional control and survival is the resection of the pelvic tumor with microscopically clear margins (R0). New ablative techniques based on ontogenetic surgical anatomy termed laterally extended endopelvic resection ( LEER ) aim at increasing the curative resection rate even of tumors extending to and fixed to the pelvic side wall ( Höckel and Dornhöfer 2006 ).
